The U.S. Centers for Disease Control and Prevention (CDC) recently awarded $2.4 million to Chicago, Houston, New York City, Philadelphia…
The World Health Organization (WHO) on Friday confirmed that a major part of the largest emergency vaccination campaign against yellow…
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) recently…
A collaborative research effort by the Johns Hopkins University School of Medicine, the National Institutes of Health and Florida State…
A research team at the National Center for Advancing Translational Sciences (NCATS) recently identified compounds that could be used to…
Researchers supported by the National Institute of Allergy and Infectious Diseases (NIAID) recently developed a novel system to grow norovirus…
The Oakland County Health Division urged residents on Wednesday to protect themselves against mosquito bites and the threat of West…
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), released a study…
Bavarian Nordic A/S released a summary of its progress for the first half of 2016 on Wednesday. “I am very…
Hologic, Inc., entered into an agreement on Tuesday worth $4.1 million with the U.S. Department of Health and Human Services’…
The Cumberland County Vector Control Office received confirmation from the Pennsylvania Department of Environmental Protection (DEP) on Thursday of positive…
U.S. Sen. Marco Rubio (R-FL) renewed his push on Thursday to reintroduce legislation that would provide additional protections from the…
The National Institutes of Health (NIH) launched a clinical trial this week for an experimental vaccine to prevent Zika virus…
The U.S. Department of Health and Human Services (HHS), the Wellcome Trust of London, the AMR Centre of Alderley Park…
Bavarian Nordic A/S initiated its Phase 1 clinical trial of MVA-BN YF on Tuesday to protect against yellow fever virus.…
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), released…
University of Texas Medical Branch (UTMB) at Galveston researchers, working in collaboration with colleagues from Mexico, recently discovered a direct…
U.S. Rep. Dan Donovan (R-NY) on Tuesday decried actions by his congressional colleagues for jeopardizing the development of a vaccine…
The U.S. Food and Drug Administration (FDA) began a series of actions this week designed to combat the emerging threat…
The U.S. Centers for Disease Control and Prevention (CDC) released a detailed account on Thursday of the agency’s response to…
A team at the Edgewood Chemical Biological Center (ECBC) has developed a means for Department of Defense (DoD) labs across…
The Infectious Diseases Society of America (IDSA) announced its support on Thursday for a bill authored by U.S. Sen. Angus…
The National Institute of Allergy and Infectious Diseases (NIAID) provided BioCryst Pharmaceuticals with additional funding on Monday for efficacy studies…
The Partnership for Research on Ebola virus in Liberia (PREVAIL) on Monday opened PREVAIL IV, a treatment trial for men…
A coalition of research institutions published a report in the Clinical Infectious Disease Journal on Wednesday that analyzed the immune…
The National International Health Regulations (IHR) of the United States notified the Pan-American Health Organization (PAHO) and the World Health…
This website uses cookies.